MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.healun.2009.05.027

Медицинская библиотека · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2009

Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study.

Kirk Richard, Naftel David, Hoffman Timothy M, Almond Christopher, Boyle Gerard, Caldwell Randall L, Kirklin James K, White Kirstie, Dipchand Anne I, Pediatric Heart Transplant Study Investigators

Сравнительное исследованиеСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

The course of dilated cardiomyopathy (DCM) leading to heart failure in children varies; survival with conventional treatment is 64% at 5 years. Heart transplantation (HTx) enables improved survival; however, outcomes from listing for transplant are not well described. This study reports survival of patients with DCM from listing with the availability of mechanical bridge to transplant.

METHODS

Patients with a primary diagnosis of DCM (n = 1,098) were identified from a multi-institutional, prospective, registry of patients aged < 18 years listed for HTx from January 1, 1993, to December 31, 2006.

RESULTS

Characteristics of DCM patients at listing included a mean age of 7.3 years; 51% male, 64% white ethnicity, 77% United Network for Organ Sharing status I, 66% on inotropic support, 28% mechanically ventilated, and 15% on mechanical support. Waitlist mortality was 11%, and 75% underwent HTx at 2 years after listing. Overall 10-year survival after listing was 72%, with higher risk of death associated with arrhythmias, mechanical ventilation, and extracorporeal membrane oxygenation (ECMO) support, but not ventricular assist device (VAD) support. Survival at 10 years post-HTx was 72%, with a higher risk of death associated with black race, older age, mechanical ventilation, longer ischemic time, and earlier era of transplant.

CONCLUSIONS

Transplantation for DCM in the pediatric population offers enhanced survival compared with the natural history. Overall waitlist mortality for DCM is low, with the exception of patients on ECMO, mechanically ventilated, or with arrhythmias. DCM patients fared well after transplant, making HTx a key therapeutic intervention.

Для цитирования: Kirk Richard, Naftel David, Hoffman Timothy M, Almond Christopher, Boyle Gerard, Caldwell Randall L, Kirklin James K, White Kirstie, Dipchand Anne I, Pediatric Heart Transplant Study Investigators. Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2009. DOI: 10.1016/j.healun.2009.05.027.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.